FDA approves Afrezza inhalable insulin for diabetics. Buh-bye needles?

Individuals with Type 1 and Type 2 diabetes now have an alternative for insulin shots. FDA finally gave its go signal to Afrezza, insulin that is administered through a whistle-sized inhaler.